SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-005170
Filing Date
2024-05-07
Accepted
2024-05-07 12:36:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27634
2 filename2.txt TEXT-EXTRACT 1425
  Complete submission text file 0000000000-24-005170.txt   40434
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filed for) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-279067
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)